Shareholders Equity and Dividend Restrictions (Details) - USD ($) $ in Billions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Equity [Abstract] | |||
Net income | $ 5.3 | $ 5.7 | $ 3.4 |
Surplus | 14.9 | $ 16.4 | $ 13.3 |
Minimum statutory surplus required by regulators | 4.8 | ||
Investments on deposit with regulatory bodies | 0.3 | ||
Maximum dividend distributions permitted in 2024 without regulatory approval | 2.1 | ||
Maximum loans to the parent company permitted without regulatory approval | 1.4 | ||
Restricted GAAP net assets of The Cigna Group's subsidiaries | 12.3 | ||
Undistributed earnings from equity method subidiaries | $ 1.0 |
X | ||||||||||
- Definition Maximum permitted amount certain of the Company's life insurance subsidiaries may loan to the parent company without prior approval from the state's Department of Insurance. No definition available.
|
X | ||||||||||
- Definition Amount of restricted net assets of consolidated and unconsolidated subsidiaries as of the end of the most recently completed fiscal year. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50 percent or less owned persons accounted for by the equity method (equity method investees). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of dividends available for payment after computation of statutory restrictions on capital surplus. No definition available.
|
X | ||||||||||
- Definition Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of statutory capital and surplus computed using statutory accounting practices prescribed by the National Association of Insurance Commissioners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|